| Product Code: ETC6249211 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahamas Lung Cancer Liquid Biopsy Market Overview |
3.1 Bahamas Country Macro Economic Indicators |
3.2 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Bahamas Lung Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 Bahamas Lung Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Bahamas Lung Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in the Bahamas |
4.2.2 Growing awareness about the benefits of liquid biopsy over traditional tissue biopsy |
4.2.3 Technological advancements in liquid biopsy techniques |
4.3 Market Restraints |
4.3.1 High cost associated with liquid biopsy tests |
4.3.2 Limited accessibility to advanced healthcare facilities in remote areas of the Bahamas |
5 Bahamas Lung Cancer Liquid Biopsy Market Trends |
6 Bahamas Lung Cancer Liquid Biopsy Market, By Types |
6.1 Bahamas Lung Cancer Liquid Biopsy Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By CTC (Circulating Tumor Cells), 2021- 2031F |
6.1.4 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By ctDNA (Circulating tumor DNA), 2021- 2031F |
6.1.5 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Exosomes and RNA, 2021- 2031F |
6.2 Bahamas Lung Cancer Liquid Biopsy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Small CellLung Cancer, 2021- 2031F |
6.2.3 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021- 2031F |
6.3 Bahamas Lung Cancer Liquid Biopsy Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Diagnostic and Imaging Centres, 2021- 2031F |
6.3.3 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Bahamas Lung Cancer Liquid Biopsy Market Revenues & Volume, By Academic and Research Centers, 2021- 2031F |
7 Bahamas Lung Cancer Liquid Biopsy Market Import-Export Trade Statistics |
7.1 Bahamas Lung Cancer Liquid Biopsy Market Export to Major Countries |
7.2 Bahamas Lung Cancer Liquid Biopsy Market Imports from Major Countries |
8 Bahamas Lung Cancer Liquid Biopsy Market Key Performance Indicators |
8.1 Adoption rate of liquid biopsy testing among healthcare providers in the Bahamas |
8.2 Number of research studies and publications validating the effectiveness of liquid biopsy for lung cancer detection |
8.3 Investment in research and development of new liquid biopsy technologies |
9 Bahamas Lung Cancer Liquid Biopsy Market - Opportunity Assessment |
9.1 Bahamas Lung Cancer Liquid Biopsy Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Bahamas Lung Cancer Liquid Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Bahamas Lung Cancer Liquid Biopsy Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Bahamas Lung Cancer Liquid Biopsy Market - Competitive Landscape |
10.1 Bahamas Lung Cancer Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 Bahamas Lung Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here